+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Hyperopia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • PDF Icon

    Report

  • 100 Pages
  • June 2025
  • Region: Global
  • BIS Research
  • ID: 6102010
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Hyperopia is a refractive error in the eye, commonly known as farsightedness. It occurs when light entering the eye is focused behind the retina rather than directly on it, making nearby objects appear blurred while distant objects are seen more clearly. Hyperopia is often caused by the eye being too short or the cornea having insufficient curvature. The condition can be present from birth, and its severity can vary. Symptoms of hyperopia may include difficulty reading, eye strain, headaches, and blurred vision for close-up tasks. It is typically corrected with glasses, contact lenses, or refractive surgeries like LASIK to help focus light properly onto the retina.

One of the key drivers of the Hyperopia market is the aging population. As people age, the natural ability of the eye to focus on close objects diminishes, a condition known as presbyopia, which is closely related to hyperopia. With the global population aging, the incidence of hyperopia and presbyopia is increasing, leading to a higher demand for vision correction solutions. Additionally, the growing use of digital devices like smartphones, computers, and tablets is contributing to digital eye strain, which exacerbates the symptoms of hyperopia. This has further fueled the demand for glasses, contact lenses, and advanced laser vision correction procedures, driving significant growth in the hyperopia market. The increasing awareness of available treatments and advancements in eyewear technology also play a role in expanding market opportunities.

Despite the growth of the Hyperopia market, several challenges continue to hinder its progress. One of the primary challenges is the high cost of treatments, particularly for advanced solutions like laser eye surgeries (such as LASIK or PRK) and premium contact lenses. While these treatments can offer long-term benefits, the initial cost can be a barrier for many patients, especially in emerging markets or for individuals without comprehensive health insurance coverage. Additionally, the lack of awareness about available treatments and the need for regular eye exams often results in delayed diagnosis, which can lead to complications or worsening of hyperopia. Another challenge is the patient resistance to surgical interventions due to concerns about safety, potential side effects, or the perceived risks of surgery. Lastly, while eyeglasses and contact lenses are common solutions, they do not provide a permanent fix, and many individuals require ongoing maintenance or frequent replacements, which can be a significant burden over time.

The global Hyperopia market is highly competitive, with several leading companies driving innovation and market growth. Companies such as Essilor Luxottica, AbbVie Inc. (Allergan), Bausch Health Companies Inc., Alcon Inc., The Cooper Companies Inc., Orasis Pharmaceuticals, and Regeneron Pharmaceuticals are at the forefront of providing cutting-edge solutions for hyperopia treatment and vision correction. Essilor Luxottica dominates the market with its extensive portfolio of eyewear and lenses, offering high-definition lenses and progressive lenses tailored for hyperopia. AbbVie (Allergan) has introduced Vuity, a novel pharmacologic treatment for presbyopia, a condition related to hyperopia. Bausch Health, through its Bausch + Lomb division, provides both contact lenses and laser surgery technologies, while Alcon focuses on advanced LASIK and contact lenses. The Cooper Companies Inc., with its CooperVision brand, specializes in contact lenses, offering high-quality solutions for hyperopia. Orasis Pharmaceuticals is developing promising pharmaceutical treatments like CSF-1 to treat presbyopia and hyperopia non-surgically. Regeneron Pharmaceuticals, although known for its work in ocular diseases, is also positioned to influence the broader eye care market. These companies are leading the way in developing innovative products and therapies, offering a wide range of options to effectively treat hyperopia and meet the growing demand for vision correction solutions.

Market Segmentation:

Segmentation 1: by Region

  • North America
  • Europe
  • Asia-Pacific
The global Hyperopia market is undergoing significant transformation, fueled by emerging trends that are reshaping the way hyperopia is managed and treated. Key drivers of this transformation include advancements in laser surgery technologies like LASIK and PRK, which are becoming more precise, less invasive, and more widely available. These innovations are making surgical treatments for hyperopia more accessible and effective, with quicker recovery times and higher success rates.

Additionally, the increasing adoption of smart eyewear and adaptive lenses that cater to the changing needs of individuals, especially in the context of digital eye strain caused by prolonged screen time, is contributing to a shift in market demand. Companies are also focusing on personalized vision correction solutions, offering customized contact lenses and high-definition eyeglasses that provide greater comfort and precision for individuals with hyperopia. The rise in pharmaceutical treatments, such as eye drops for presbyopia (a condition often linked to hyperopia), is further driving market growth by providing non-surgical alternatives for vision correction. The growing awareness of eye health and the increasing availability of affordable solutions, including blue light-blocking lenses and multifocal contact lenses, are also contributing to the expanding market. These trends are collectively transforming the hyperopia market, making treatments more effective, accessible, and personalized for a wider range of consumers.

This product will be delivered within 3-5 business days.

Table of Contents

Executive SummaryScope and DefinitionMarket/Product DefinitionInclusion and ExclusionKey Questions AnsweredAnalysis and Forecast Note
1. Global Hyperopia Market: Industry Outlook
1.1 Introduction
1.2 Market Trends
1.3 Regulatory Framework
1.4 Epidemiology Analysis
1.5 Clinical Trial Analysis
1.6 Market Dynamics
1.6.1 Impact Analysis
1.6.2 Market Drivers
1.6.3 Market Challenges
1.6.4 Market Opportunities
2. Global Hyperopia Market (Region), ($Billion), 2023-2035
2.1 North America
2.1.1 Key Findings
2.1.2 Market Dynamics
2.1.3 Market Sizing and Forecast
2.1.3.1 North America Hyperopia Market, by Country
2.1.3.1.1 U.S.
2.2 Europe
2.2.1 Key Findings
2.2.2 Market Dynamics
2.2.3 Market Sizing and Forecast
2.2.3.1 Europe Hyperopia Market, by Country
2.2.3.1.1 Germany
2.2.3.1.2 U.K.
2.2.3.1.3 France
2.2.3.1.4 Italy
2.3 Asia Pacific
2.3.1 Key Findings
2.3.2 Market Dynamics
2.3.3 Market Sizing and Forecast
2.3.3.1 Asia Pacific Hyperopia Market, by Country
2.3.3.1.1 China
2.3.3.1.2 Japan
3. Global Hyperopia Market: Competitive Landscape and Company Profiles
3.1 Key Strategies and Development
3.1.1 Mergers and Acquisitions
3.1.2 Synergistic Activities
3.1.3 Business Expansions and Funding
3.1.4 Product Launches and Approvals
3.1.5 Other Activities
3.2 Company Profiles
3.2.1 Essilor Luxottica
3.2.1.1 Overview
3.2.1.2 Top Products / Product Portfolio
3.2.1.3 Top Competitors
3.2.1.4 Target Customers/End-Users
3.2.1.5 Key Personnel
3.2.1.6 Analyst View
3.2.2 AbbVie Inc. (Allergan)
3.2.2.1 Overview
3.2.2.2 Top Products / Product Portfolio
3.2.2.3 Top Competitors
3.2.2.4 Target Customers/End-Users
3.2.2.5 Key Personnel
3.2.2.6 Analyst View
3.2.3 Bausch Health Companies Inc.
3.2.3.1 Overview
3.2.3.2 Top Products / Product Portfolio
3.2.3.3 Top Competitors
3.2.3.4 Target Customers/End-Users
3.2.3.5 Key Personnel
3.2.3.6 Analyst View
3.2.4 Alcon Inc.
3.2.4.1 Overview
3.2.4.2 Top Products / Product Portfolio
3.2.4.3 Top Competitors
3.2.4.4 Target Customers/End-Users
3.2.4.5 Key Personnel
3.2.4.6 Analyst View
3.2.5 The Cooper Companies Inc.
3.2.5.1 Overview
3.2.5.2 Top Products / Product Portfolio
3.2.5.3 Top Competitors
3.2.5.4 Target Customers/End-Users
3.2.5.5 Key Personnel
3.2.5.6 Analyst View
3.2.6 Orasis Pharmaceuticals
3.2.6.1 Overview
3.2.6.2 Top Products / Product Portfolio
3.2.6.3 Top Competitors
3.2.6.4 Target Customers/End-Users
3.2.6.5 Key Personnel
3.2.7 Regeneron Pharmaceuticals
3.2.7.1 Overview
3.2.7.2 Top Products / Product Portfolio
3.2.7.3 Top Competitors
3.2.7.4 Target Customers/End-Users
3.2.7.5 Key Personnel
3.2.7.6 Analyst View
4. Research Methodology
List of Figures
Figure: Global Hyperopia Market (by Region), $Billion, 2024 and 2035
Figure: Global Hyperopia Market Key Trends, Analysis
List of Tables
Table: Global Hyperopia Market Dynamics, Impact Analysis
Table: Global Hyperopia Market (by Region), $Billion, 2024-2035

Companies Mentioned

  • Essilor Luxottica
  • AbbVie Inc. (Allergan)
  • Bausch Health Companies Inc.
  • Alcon Inc.
  • The Cooper Companies Inc.
  • Orasis Pharmaceuticals
  • Regeneron Pharmaceuticals